HLA-DR Antibody, anti-human, APC-Vio® 770, REAfinity™ 130-111-792 from Miltenyi Biotec

Product Specs
ItemHLA-DR Antibody, anti-human, APC-Vio® 770, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-111-792
Quantity100 tests in 200 µL
ApplicationsFlow cytometry
Conjugate/TagAPC-Vio 770
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
IsotypeIgG1
CloneREA805
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
NCBI Full Gene Namemajor histocompatibility complex, class II, DR beta 3, major histocompatibility complex, class II, DR beta 5, major histocompatibility complex, class II, DR beta 4, major histocompatibility complex, class II, DR alpha, major histocompatibility complex, class II, DR beta 1
NCBI Gene AliasesHLA-DRB3*, HLA-DRB, HLA-DRA1, HLA-DPB1, SS1, DR4, HLA-DR3B, HLA-DRB4*, HLA-DR1B, HLA-DRB5*, DRB4, HLA-DR4B, DRB1, DRB3
Clonalitymonoclonal
Reactivityhuman, non-human primate
Concentration1:50
ModificationsRecombinantly engineered
TargetHLA-DR
Research AreaFor research use only
Regulatory StatusFor research use only

Add to Compare List

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Modeling glioblastoma heterogeneity as a dynamic network of cell statesMolecular Systems BiologySeptember 16, 2021Ida Larsson, Erika Dalmo, Ramy Elgendy, Mia Niklasson, Milena Doroszko, Anna Segerman, Rebecka Jörnsten, Bengt Westermark, Sven NelanderPharMingen, #562789), CD44‐FITC (BD PharMingen, #555478), and HLA‐DR‐APC‐Vio770 (Miltenyi Biotec, #130‐111‐792). Isotype control antibodies for each fluorophore were from the same companies as the primary antibodies.

(2) Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expressionJournal of immunology (Baltimore, Md. : 1950)July 15, 1986Edwards JA, Durant BM, Jones DB, Evans PR, Smith JL.

(3) A matrix approach to human class II histocompatibility antigens: reactions of four monoclonal antibodies with the products of nine haplotypesImmunogeneticsJanuary 1, 1984Brodsky FM.